{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase II\/III study of paclitaxel\/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcom","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-ii-iii-study-of-paclitaxel-carboplatin-alone-or-combined-with-either-trastuzumab-and-hyaluronidase-oysk-herceptin-hylecta-or-pertuzumab-trastuzumab-and-hyaluronidase-zzfx-phesgo-in-her2-po\/#breadcrumbitem"}]}